Author:
Heil G.,Freund M.,Link H.,Mitrou P.,Hoelzer D.,Wandt H.,Ehninger G.,Fackler-Schwalbe E.,Schlimok G.,Lösch A.,Queißer W.,Löffler B.,Kurrle E.
Publisher
Springer Berlin Heidelberg
Reference19 articles.
1. Gale PR, Büchner T (1989) Acute leukemias: prognostic factors and treatment strategies. Leukemia 3: 758–761
2. Welborn JL, Lewis JP, Meyers F (1989) Impact of reinduction regimens on the clinical course of adult acute nonlymphocytic leukemia. Leukemia 11: 711–716
3. Büchner T, Hiddemann W (1990) Treatment strategies in acute myeloid leukemia (AML) A. First line chemotherapy. Blut 60: 61–67
4. Appelbaum FR, Dahlberg S, Thomas ED, Buckner CD, Cheever MA, Clift RA, Crowley J, Deeg HJ, Fefer A, Greenberg PD, Kadin M, Smith W, Stewart P, Sullivan K, Storb R, Weiden P (1984) Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. Ann Intern Med 101: 581–588
5. Champlin R, Ho W, Winston D, Decker R, Greenberg P, Burnison M, Holly FE, Gale RP (1987) Treatment of adults with acute myelogenous leukemia: prospective evaluation of high-dose cytarabine in consolidation chemotherapy and with bone marrow transplantation. Semin Oncol 14 [Suppl 1]: 1–6